Add BrightSurf on Google Email

JAMA Network


Cervical cancer mortality among US women younger than age 25

A significant drop in cervical cancer mortality among US women younger than age 25 has been observed, according to a recent study published in JAMA Network. The findings indicate that widespread HPV vaccination is driving this decline, reducing the prevalence of HPV infection and subsequent cervical cancer incidence.

SourceJAMA Network·JournalJAMA·DateNov 27, 2024

Alcohol use and antiobesity medication treatment

A cohort study found that nearly half of participants who consumed alcohol at baseline decreased their alcohol use after initiating anti-obesity medication treatment. The medications, such as naltrexone and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), may have properties that lead to reduced cravings for alcohol.

SourceJAMA Network·JournalJAMA Network Open·DateNov 26, 2024

Wildfire smoke exposure and incident dementia

A cohort study found that long-term exposure to wildfire and fine particulate matter was associated with dementia diagnoses. The study suggests that reducing wildfire PM2.5 exposure could decrease dementia diagnoses and address health disparities.

SourceJAMA Network·JournalJAMA Neurology·DateNov 25, 2024

Obesity prevention at an early age

The Greenlight Plus trial found that technological interventions and policies can help prevent childhood obesity at an early age. The study suggests that targeted prevention efforts can reduce the risk of obesity in children, setting a promising foundation for future prevention strategies.

SourceJAMA Network·JournalJAMA·DateNov 21, 2024

Early adoption of sodium-glucose cotransporter-2 inhibitor in patients hospitalized with heart failure with mildly reduced or preserved ejection fraction

Prescription rates of sodium-glucose cotransporter-2 inhibitors increased substantially within 2 years after publication of clinical trial evidence documenting benefit. The study highlights the need to understand strategies used by higher prescribing centers to increase SGLT2i adoption.

SourceJAMA Network·JournalJAMA Cardiology·DateNov 18, 2024